3,4'-5-trihydroxystlbenes compounds with functions of reducing pulmonary artery high pressure and improving respiration function
Patent Information
- Authority / Receiving Office
- CN · China
- Current Assignee / Owner
- 陕西赛德高科生物股份有限公司
- Publication Date
- 2003-03-12
- Estimated Expiration
- Not applicable · inactive patent
Abstract
Description
[0001] 1. Field
[0002] The present invention belongs to the category of medicine (A61p11 / ), relates to a polydatin compound, in particular to a polydatin compound (polydatin, a compound with a stilbene triphenol structure) for reducing pulmonary hypertension and improving respiratory function ). 2. Background technology
[0003] In recent years, due to environmental pollution and other reasons, the incidence and harmfulness of cor pulmonale have become increasingly serious, making the development of drugs that can effectively regulate pulmonary arterial pressure (hph) and prevent and treat cor pulmonale more important. At present, there are many related reports at home and abroad. Vasodilator drugs are the most researched drug therapy, but the clinical effect of existing therapeutic drugs is not satisfactory, this is because: (1) most of the existing drugs for lowering pulmonary arterial pressure (except inhaled NO) are for the treatment of hypertension The drug lacks speci...